134 results
Page 4 of 7
6-K
EX-1.1
436zp28o
11 Feb 22
Current report (foreign)
5:29pm
424B5
wyvpj 9qlprftj
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
EX-99.2
4wkigppe2bd
15 Nov 21
VBL Therapeutics Reports Third Quarter 2021 Financial Results
7:00am
6-K
EX-99.3
a85xs5t3na751o8t0 bc
15 Nov 21
VBL Therapeutics Reports Third Quarter 2021 Financial Results
7:00am
6-K
n5rqgre lmuypr9mx
20 Oct 21
Current report (foreign)
4:01pm
6-K
EX-99.1
m8ziuki8g05my5bk
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
EX-99.2
0kfbjqxm4s 50uqowbi7
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
yg6 1ynevu
16 Aug 21
Current report (foreign)
7:00am
6-K
tub6524thtdgy ufux
11 May 21
Current report (foreign)
7:00am
POS AM
gr3a g3ll9kemq9o
19 Apr 21
Prospectus update (post-effective amendment)
5:17pm
424B8
5h3k95q7 q9
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
EX-1.1
01cqmeh3chkz
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
b2i4o68z0 i28f
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
zplcigygcuctx1pbj
9 Apr 21
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
mydrtxgzlfima6ydmih
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
424B5
istge7r5 y5o0jm
15 Jan 21
Prospectus supplement for primary offering
7:00am
F-3
n2easy 68uq2pgynd
30 Dec 20
Shelf registration (foreign)
4:17pm
424B3
uyyjww67n7c g3
16 Nov 20
Prospectus supplement
7:15am
6-K
280wn91
16 Nov 20
Current report (foreign)
7:00am